Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose

<p dir="ltr">Diabetes-associated long-term hyperglycaemia leads to oxidative stress-mediated fibrosis in different tissues and organs. Endothelial-to-mesenchymal-transition (EndMT) appears to play a role in diabetes-associated fibrotic conditions. Here, we investigate whether EndMT i...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Roberta Giordo (299595) (author)
مؤلفون آخرون: Gheyath K. Nasrallah (2182598) (author), Anna Maria Posadino (299594) (author), Francesco Galimi (3419783) (author), Giampiero Capobianco (299601) (author), Ali Hussein Eid (16442185) (author), Gianfranco Pintus (91638) (author)
منشور في: 2021
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513564217180160
author Roberta Giordo (299595)
author2 Gheyath K. Nasrallah (2182598)
Anna Maria Posadino (299594)
Francesco Galimi (3419783)
Giampiero Capobianco (299601)
Ali Hussein Eid (16442185)
Gianfranco Pintus (91638)
author2_role author
author
author
author
author
author
author_facet Roberta Giordo (299595)
Gheyath K. Nasrallah (2182598)
Anna Maria Posadino (299594)
Francesco Galimi (3419783)
Giampiero Capobianco (299601)
Ali Hussein Eid (16442185)
Gianfranco Pintus (91638)
author_role author
dc.creator.none.fl_str_mv Roberta Giordo (299595)
Gheyath K. Nasrallah (2182598)
Anna Maria Posadino (299594)
Francesco Galimi (3419783)
Giampiero Capobianco (299601)
Ali Hussein Eid (16442185)
Gianfranco Pintus (91638)
dc.date.none.fl_str_mv 2021-02-02T00:00:00Z
dc.identifier.none.fl_str_mv 10.3390/antiox10020224
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Resveratrol-Elicited_PKC_Inhibition_Counteracts_NOX-Mediated_Endothelial_to_Mesenchymal_Transition_in_Human_Retinal_Endothelial_Cells_Exposed_to_High_Glucose/23576079
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Medical biochemistry and metabolomics
resveratrol
diabetes
fibrosis
NOX
oxidative stress
EndMT
retinopathy
dc.title.none.fl_str_mv Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Diabetes-associated long-term hyperglycaemia leads to oxidative stress-mediated fibrosis in different tissues and organs. Endothelial-to-mesenchymal-transition (EndMT) appears to play a role in diabetes-associated fibrotic conditions. Here, we investigate whether EndMT is implicated in the diabetic retinopathy fibrotic process and evaluate the possibility that resveratrol could counteract EndMT by inhibiting high glucose (HG)-induced increases in ROS. Primary Human Retinal Endothelial Cells (HRECs) were either pre-treated for 24 h with 1 µM resveratrol or left untreated, then glucose (30 mM) was applied at 3-day intervals for 10 days. qRT-PCR and ELISA were used to detect mRNA or protein expression of endothelial markers (CD31, CDH5, vWF) or mesenchymal markers (VIM, αSMA and collagen I), respectively. Intracellular ROS levels were measured with carboxy-DCFDA, while NOX-associated ROS levels were evaluated using the NADPH-specific redox biosensor p47-roGFP. Treatment of HRECs with HG increased intracellular ROS levels and promoted phenotype shifting towards EndMT, evidenced by decreased expression of endothelial markers concomitant with increased expression of mesenchymal ones. HG-induced EndMT appears to be mediated by NADPH-associated ROS generation as pre-treatment of HRECs with resveratrol or the NADPH inhibitor, diphenyleneiodonium chloride (DPI), attenuated ROS production and EndMT transition, suggesting that the effect of resveratrol on HG-induced ROS occurs via down-regulation of NADPH oxidase. It is worth noting that resveratrol or Chelerythrine, a Protein kinase C (PKC) inhibitor, reduce ROS and EndMT in HG-exposed cells, suggesting that NADPH activation occurs via a PKC-dependent mechanism. Taken together, our results provide the basis for a resveratrol-based potential protective therapy to prevent diabetic-associated complications.</p><h2>Other Information</h2><p dir="ltr">Published in: Antioxidants<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.3390/antiox10020224" target="_blank">http://dx.doi.org/10.3390/antiox10020224</a></p>
eu_rights_str_mv openAccess
id Manara2_cb169552b2066c111aaedbb587bd388c
identifier_str_mv 10.3390/antiox10020224
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/23576079
publishDate 2021
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High GlucoseRoberta Giordo (299595)Gheyath K. Nasrallah (2182598)Anna Maria Posadino (299594)Francesco Galimi (3419783)Giampiero Capobianco (299601)Ali Hussein Eid (16442185)Gianfranco Pintus (91638)Biological sciencesBiochemistry and cell biologyBiomedical and clinical sciencesMedical biochemistry and metabolomicsresveratroldiabetesfibrosisNOXoxidative stressEndMTretinopathy<p dir="ltr">Diabetes-associated long-term hyperglycaemia leads to oxidative stress-mediated fibrosis in different tissues and organs. Endothelial-to-mesenchymal-transition (EndMT) appears to play a role in diabetes-associated fibrotic conditions. Here, we investigate whether EndMT is implicated in the diabetic retinopathy fibrotic process and evaluate the possibility that resveratrol could counteract EndMT by inhibiting high glucose (HG)-induced increases in ROS. Primary Human Retinal Endothelial Cells (HRECs) were either pre-treated for 24 h with 1 µM resveratrol or left untreated, then glucose (30 mM) was applied at 3-day intervals for 10 days. qRT-PCR and ELISA were used to detect mRNA or protein expression of endothelial markers (CD31, CDH5, vWF) or mesenchymal markers (VIM, αSMA and collagen I), respectively. Intracellular ROS levels were measured with carboxy-DCFDA, while NOX-associated ROS levels were evaluated using the NADPH-specific redox biosensor p47-roGFP. Treatment of HRECs with HG increased intracellular ROS levels and promoted phenotype shifting towards EndMT, evidenced by decreased expression of endothelial markers concomitant with increased expression of mesenchymal ones. HG-induced EndMT appears to be mediated by NADPH-associated ROS generation as pre-treatment of HRECs with resveratrol or the NADPH inhibitor, diphenyleneiodonium chloride (DPI), attenuated ROS production and EndMT transition, suggesting that the effect of resveratrol on HG-induced ROS occurs via down-regulation of NADPH oxidase. It is worth noting that resveratrol or Chelerythrine, a Protein kinase C (PKC) inhibitor, reduce ROS and EndMT in HG-exposed cells, suggesting that NADPH activation occurs via a PKC-dependent mechanism. Taken together, our results provide the basis for a resveratrol-based potential protective therapy to prevent diabetic-associated complications.</p><h2>Other Information</h2><p dir="ltr">Published in: Antioxidants<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.3390/antiox10020224" target="_blank">http://dx.doi.org/10.3390/antiox10020224</a></p>2021-02-02T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/antiox10020224https://figshare.com/articles/journal_contribution/Resveratrol-Elicited_PKC_Inhibition_Counteracts_NOX-Mediated_Endothelial_to_Mesenchymal_Transition_in_Human_Retinal_Endothelial_Cells_Exposed_to_High_Glucose/23576079CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/235760792021-02-02T00:00:00Z
spellingShingle Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
Roberta Giordo (299595)
Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Medical biochemistry and metabolomics
resveratrol
diabetes
fibrosis
NOX
oxidative stress
EndMT
retinopathy
status_str publishedVersion
title Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_full Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_fullStr Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_full_unstemmed Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_short Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_sort Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
topic Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Medical biochemistry and metabolomics
resveratrol
diabetes
fibrosis
NOX
oxidative stress
EndMT
retinopathy